Correlation between familial cancer history and epidermal growth factor receptor mutations in Taiwanese never smokers with nonsmall cell lung cancer: A case-control study

Journal of Thoracic Disease

Volumn 7, Issue 3, 2015, Pages 281-287

  Cheng, Po Chung ^a   Cheng, Yun Chung ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Epidermal growth factor receptor (EGFR); Family; Lung neoplasms; Non small cell lung cancer (NSCLC); Risk factors

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; EGFR GENE; FAMILY ASSESSMENT; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEVER SMOKER; NON SMALL CELL LUNG CANCER; PREVALENCE; RETROSPECTIVE STUDY; SMOKING; TAIWAN; TAIWANESE; TERTIARY CARE CENTER;

EID: 84928625964     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2015.02.03     Document Type: Article

References (32)

1. Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010;19:1893-907.
2. Molina JR, Adjei AA, Jett JR. Advances in chemotherapy of non-small cell lung cancer. Chest 2006;130:1211-9.
3. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-36.
4. U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta: U.S. 2014.
5. Boffetta P, Järvholm B, Brennan P, et al. Incidence of lung cancer in a large cohort of non-smoking men from Sweden. Int J Cancer 2001;94:591-3.
6. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
7. Couraud S, Zalcman G, Milleron B, et al. Lung cancer in never smokers-a review. Eur J Cancer 2012;48:1299-311.
8. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers-a different disease. Nat Rev Cancer 2007;7:778-90.
9. Li Y, Sheu CC, Ye Y, et al. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol 2010;11:321-30.
10. Brennan P, Hainaut P, Boffetta P. Genetics of lung-cancer susceptibility. Lancet Oncol 2011;12:399-408.
11. Cooper WA, Lam DC, O'Toole SA, et al. Molecular biology of lung cancer. J Thorac Dis 2013;5:S479-90.
12. Mayne ST, Buenconsejo J, Janerich DT. Familial cancer history and lung cancer risk in United States nonsmoking men and women. Cancer Epidemiol Biomarkers Prev 1999;8:1065-9.
13. Pennell NA, Yin L, Keshtgarpour M, et al. Two generations of light/never-smokers with advanced adenocarcinoma of the lung with durable responses to erlotinib. J Thorac Oncol 2012;7:1200-1.
14. Gaughan EM, Cryer SK, Yeap BY, et al. Family history of lung cancer in never smokers with non-small-cell lung cancer and its association with tumors harboring EGFR mutations. Lung Cancer 2013;79:193-7.
15. Shi Y, Au JS, Thongprasert S, et al. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER). J Thorac Oncol 2014;9:154-62.
16. Lissowska J, Foretova L, Dabek J, et al. Family history and lung cancer risk: international multicentre case-control study in Eastern and Central Europe and meta-analyses. Cancer Causes Control 2010;21:1091-104.
17. Matakidou A, Eisen T, Houlston RS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer 2005;93:825-33.
18. Bailey-Wilson JE, Amos CI, Pinney SM, et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet 2004;75:460-74.
19. Tibaldi C, Giovannetti E, Vasile E, et al. Inherited germline T790M mutation and somatic epidermal growth factor receptor mutations in non-small cell lung cancer patients. J Thorac Oncol 2011;6:395-6.
20. Nomura M, Shigematsu H, Li L, et al. Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers. PLoS Med 2007;4:e125.
21. Nitadori J, Inoue M, Iwasaki M, et al. Association between lung cancer incidence and family history of lung cancer: data from a large-scale population-based cohort study, the JPHC study. Chest 2006;130:968-75.
22. Gaughan EM, Costa DB. Genotype-driven therapies for non-small cell lung cancer: focus on EGFR, KRAS and ALK gene abnormalities. Ther Adv Med Oncol 2011;3:113-25.
23. Webb S, Thomas M, Metcalf C, et al. EGFR mutation testing in NSCLC: patterns of care and outcomes in Western Australia. Asia-Pacific Journal of Clinical Oncology 2009;5:66-71.
24. Wu YL, Chu DT, Han B, et al. Phase III, randomized, open-label, first-line study in Asia of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer: evaluation of patients recruited from mainland China. Asia Pac J Clin Oncol 2012;8:232-43.
25. Voldborg BR, Damstrup L, Spang-Thomsen M, et al. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann Oncol 1997;8:1197-206.
26. Ganti AK, Loberiza FR Jr, Kessinger A. Association of positive family history with survival of patients with lung cancer. Lung Cancer 2009;63:136-9.
27. Sharma SV, Bell DW, Settleman J, et al. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 2007;7:169-81.
28. Badar F, Meerza F, Khokhar RA, et al. Characteristics of lung cancer patients-the Shaukat Khanum Memorial experience. Asian Pac J Cancer Prev 2006;7:245-8.
29. Toh CK, Gao F, Lim WT, et al. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol 2006;24:2245-51.
30. Yu IT, Chiu YL, Au JS, et al. Dose-response relationship between cooking fumes exposures and lung cancer among Chinese nonsmoking women. Cancer Res 2006;66:4961-7.
31. Siegfried JM. Women and lung cancer: does oestrogen play a role? Lancet Oncol 2001;2:506-13.
32. Levin ER. Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol Endocrinol 2003;17:309-17.